The First Organocatalytic Enantio- and Diastereoselective 1,3-Dipolar Cycloaddition of Azomethine Ylides with Nitroalkenes

Meng-Xia Xue; Xiao-Mei Zhang; Liu-Zhu Gong

doi:10.1055/s-2008-1042802

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2008(5): 691-694
DOI: 10.1055/s-2008-1042802

LETTER

The First Organocatalytic Enantio- and Diastereoselective 1,3-Dipolar Cycloaddition of Azomethine Ylides with Nitroalkenes

Meng-Xia Xue^a,c, Xiao-Mei Zhang*^a, Liu-Zhu Gong^a,b
^a Key Laboratory for Asymmetric Synthesis & Chirotechnology of Sichuan Province, Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu 610041, P. R. of China
Fax: +86(28)85229250; e-Mail: xmzhang@cioc.ac.cn;
^b Hefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei, 230026, P. R. of China
^c Graduate School of Chinese Academy of Sciences, Beijing, 100049, P. R. of China

Further Information

Publication History

Received 29 October 2007
Publication Date:
26 February 2008 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

The first chiral thiourea-catalyzed stereoselective 1,3- dipolar cycloaddition of azomethine ylides with nitroalkenes afforded highly substituted pyrrolidines with high diastereoselectivities of up to >99:1 dr and moderate enantioselectivities.

Key words

organocatalysis - 1,3-dipolar cycloaddition - azomethine ylides - nitroalkenes

References and Notes

1 Harwood LM. Vickers RJ. In Synthetic Applications of 1,3-Dipolar Cycloaddition Chemistry toward Heterocycles and Natural Products Padwa A. Pearson W. Wiley and Sons; New York: 2002. Chap. 3.

Google Scholar
2a Markó IE. In Comprehensive Organic Synthesis Vol. 3: Trost BM. Fleming I. Pergamon; Oxford: 1991. p.913-974

Crossref PubMed Google Scholar
2b Najera C. Sansano JM. Angew. Chem. Int. Ed. 2005, 44: 6272

Crossref PubMed Google Scholar
2c Gothelf KV. In Cycloaddition Reactions in Organic Synthesis Kobayashi S. Jørgensen KA. Wiley-VCH; Weiheim: 2002. p.211

Crossref PubMed Google Scholar
2d Gothelf KV. Jørgensen KA. Chem. Rev. 1998, 98: 863

Crossref PubMed Google Scholar
3 Gothelf AS. Gothelf KV. Hazell RG. Jørgensen KA. Angew. Chem. Int. Ed. 2002, 41: 4236

Crossref PubMed Google Scholar
4a Zeng W. Zhou YG. Org. Lett. 2005, 7: 5055

Crossref Google Scholar
4b Stohler R. Wahl F. Pfaltz A. Synthesis 2005, 1431

Crossref Google Scholar
4c Knopfel TF. Aschwanden P. Ichikawa T. Watanabe T. Carreira EM. Angew. Chem. Int. Ed. 2004, 43: 5971

Crossref Google Scholar
4d Chen C. Li X. Schreiber SL. J. Am. Chem. Soc. 2003, 125: 10174

Crossref Google Scholar
4e Longmire JM. Wang B. Zhang XM. J. Am. Chem. Soc. 2002, 124: 13400

Crossref Google Scholar
5a Yan XX. Peng Q. Zhang Y. Zhang K. Hong W. Hou XL. Wu YD. Angew. Chem. Int. Ed. 2006, 45: 1979

Crossref Google Scholar
5b Cabrera S. Arrayas RG. Carretero JC. J. Am. Chem. Soc. 2005, 127: 16394

Crossref Google Scholar
5c Gao WZ. Zhang XM. Raghunath M. Org. Lett. 2005, 7: 4241

Crossref Google Scholar
6 Oderaotoshi Y. Cheng WJ. Fujitomi S. Kasano Y. Minakata S. Komatsu M. Org. Lett. 2003, 5: 5043

Crossref PubMed Google Scholar
7a Jen WS. Wiener JJM. MacMillan DWC. J. Am. Chem. Soc. 2000, 122: 9874

Crossref Google Scholar
7b Alemparte C. Blay G. Jørgensen KA. Org. Lett. 2005, 7: 4569

Crossref Google Scholar
7c Chen W. Yuan XH. Li R. Du W. Wu Y. Ding LS. Chen YC. Adv. Synth. Catal. 2006, 348: 1818

Crossref Google Scholar
7d Vicario JL. Reboredo S. Badia D. Carrillo L. Angew. Chem. Int. Ed. 2007, 46: 5168

Crossref Google Scholar
7e Chen W. Du W. Duan YZ. Wu Y. Yang SY. Chen YC. Angew. Chem. Int. Ed. 2007, 46: 7667

Crossref Google Scholar
8 Berkessel A. Gröger H. In Asymmetric Organocatalysis: From Biomimetic Concept to Applications in Asymmetric Synthesis Wiley-VCH; Weinheim: 2005.

Google Scholar
9a Li BJ. Jiang L. Liu M. Chen YC. Ding LS. Wu Y. Synlett 2005, 603

Crossref Google Scholar
9b McCooey SH. Connon SJ. Angew. Chem. Int. Ed. 2005, 44: 6367

Crossref Google Scholar
9c Vakulya B. Varga S. Csámpai A. Soós T. Org. Lett. 2005, 7: 1967

Crossref Google Scholar
9d Ye JX. Dixon DJ. Hynes PS. Chem. Commun. 2005, 4481

Crossref Google Scholar
9e Tillman AL. Ye JX. Dixon DJ. Chem. Commun. 2006, 1191

Crossref Google Scholar
9f Song J. Wang Y. Deng L. J. Am. Chem. Soc. 2006, 128: 6048

Crossref Google Scholar
9g Wang YQ. Song J. Hong R. Li HM. Deng L. J. Am. Chem. Soc. 2006, 128: 8156

Crossref Google Scholar
9h Wang J. Li H. Zu LS. Jiang W. Xie HX. Duan WH. Wang W. J. Am. Chem. Soc. 2006, 128: 12652

Crossref Google Scholar
9i Bartoli G. Bosco M. Carlone A. Cavalli A. Locatelli M. Mazzanti A. Ricci P. Sambri L. Melchiorre P. Angew. Chem. Int. Ed. 2006, 45: 4966

Crossref Google Scholar
9j Bode CA. Ting A. Schaus SE. Tetrahedron 2006, 62: 11499

Crossref Google Scholar
9k Hynes PS. Stranges D. Stupple PA. Guarna A. Dixon DJ. Org. Lett. 2007, 9: 2107

Crossref Google Scholar
9l Liu TY. Cui HL. Long J. Li BJ. Wu Y. Ding LS. Chen YC. J. Am. Chem. Soc. 2007, 129: 1878

Crossref Google Scholar
9m Song J. Shih HW. Deng L. Org. Lett. 2007, 9: 603

Crossref Google Scholar
9n Wang BM. Wu FH. Wang Y. Liu XF. Deng L. J. Am. Chem. Soc. 2007, 129: 768

Crossref Google Scholar
9o Biddle MM. Lin M. Scheidt KA. J. Am. Chem. Soc. 2007, 129: 3830

Crossref Google Scholar

10

CCDC: 651568

11

General Procedure for Asymmetric 1,3-Dipolar Cycloaddition of Azomethine YlidesA tube charged with benzophenone imines 1 (0.2 mmol), nitroalkenes 2 (0.4 mmol), catalyst 4-6 (0.02 mmol) and cyclohexane (2 mL). The mixture was stirred at 40 °C for 2 d, the solvent was removed, and the residue was analyzed by ¹H NMR to determine the endo/exo ratio and purified by flash chromatography. The ee is determined by HPLC (Daicel Chirapak OD-H).

12

3,5,5-Triphenyl-2-( tert -butyloxycarbonyl)-4-nitro-pyrrolidine (3a) Yield 77%; mp 110-111 °C; [α]_D ²⁰ -6.0 (c 0.2, CH₂Cl₂; 63% ee). ¹H NMR (300 MHz, CDCl₃): δ = 1.38 (s, 9 H), 3.85 (d, J = 10.5 Hz, 1 H), 4.02 (dd, J ₁ = 4.2 Hz, J ₂ = 4.8 Hz, 1 H), 6.07 (d, J = 4.9 Hz, 1H), 6.77-6.80 (m, 2 H), 7.18-7.46 (m, 11 H), 7.82 (d, J = 7.4 Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 170.4, 142.7, 141.8, 137.4, 129.1, 128.7, 128.5, 127.9, 127.8, 127.7, 126.9, 125.5, 101.8, 82.2, 66.1, 59.1, 27.8 ppm. IR (KBr): ν = 3308, 2918, 2851, 1728, 1548, 1364, 1340, 1153, 837, 784, 706 cm^-1. HRMS (Bio TOF Q): m/z calcd for C₂₇H₂₈N₂O₄Na⁺: 467.1941; found: 467.1950. The ee is 63% determined by HPLC [Daicel Chirapak OD-H, hexane-i-PrOH (95:5), flow rate 1.0 mL/min]: t _R = 5.18 min, 6.17 min.

13

3-( p -Methoxylphenyl)-2-( tert -butyloxycarbonyl)-4-nitro-5,5-eiphenyl-pyrrolidine (3b)
Yield 63%; mp 115-116 °C; [α]_D ²⁰ -3.4 (c 0.266, CH₂Cl₂; 65% ee). ¹H NMR (300 MHz, CDCl₃): δ = 1.37 (s, 9 H), 3.75 (d, J = 8.4 Hz, 3 H), 3.84 (s, 1 H), 3.91 (s, 1 H), 3.97 (dd, J ₁ = 4.9 Hz, J ₂ = 5.0 Hz, 1 H), 6.02 (d, J = 5.1 Hz, 1 H), 6.70 (s, 4 H), 7.18-7.32 (m, 4 H), 7.41 (dd, J ₁ = 7.8 Hz, J ₂ = 17.1 Hz, 4 H), 7.79 (d, J = 7.5 Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 170.5, 159.0, 142.7, 141.9, 129.5, 129.1, 129.0, 128.5, 127.8, 127.6, 126.9, 125.5, 114.0, 101.9, 82.2, 66.2, 58.5, 55.2, 27.9 ppm. IR (KBr): ν = 3330, 2956, 2928, 2870, 1729, 1552, 1513, 1247, 832, 782, 712 cm^-1. HRMS (Bio TOF Q): m/z calcd for C₂₈H₃₀N₂O₅Na⁺: 497.2047; found: 497.2036. The ee is 65% determined by HPLC [Daicel Chirapak OD-H, hexane-i-PrOH (98:2), flow rate 1.0 mL/min]: t _R = 8.90 min, 10.10 min.

14

3-( p -Methylphenyl)-2-( tert -butyloxycarbonyl)-4-nitro-5,5-diphenyl-pyrrolidine (3c) Yield 56%; mp 99-100 °C; [α]_D ²⁰ -7.5 (c 0.332, CH₂Cl₂; 62% ee). ¹H NMR (300 MHz, CDCl₃): δ = 1.37 (s, 9 H), 2.27 (s, 3 H), 3.83 (d, J = 9.3 Hz, 1 H), 3.99 (dd, J ₁ = 4.8 Hz, J ₂ = 4.8 Hz, 1 H), 6.04 (d, J = 4.8 Hz, 1 H), 6.67 (d, J = 8.1 Hz, 2 H), 6.98 (d, J = 7.8 Hz, 2 H), 7.18-7.39 (m, 6 H), 7.42-7.46 (m, 4 H), 7.81 (d, J = 1.2 Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 170.5, 142.7, 141.9, 137.4, 134.4, 129.3, 129.0, 128.5, 127.7, 127.6, 126.9, 125.5, 101.8, 82.2, 66.1, 58.8, 27.8 ppm. IR (KBr): ν = 3454, 3311, 2971, 2925, 2866, 1728, 1547, 1448, 1365, 1339, 1152, 838, 785, 744, 705 cm^-1. HRMS (Bio TOF Q): m/z calcd for C₂₈H₃₀N₂O₄Na⁺: 481.2098; found: 481.2088. The ee is 62% determined by HPLC [Daicel Chirapak OD-H, hexane-i-PrOH (98:2), flow rate 1.0 mL/min]: t _R = 5.75 min, 6.96 min.

15

3-( m -Methylphenyl)-2-( tert -butyloxycarbonyl)-4-nitro-5,5-diphenyl-pyrrolidine (3d)
Yield 68%; mp 113-114 °C; [α]_D ²⁰ +4.0 (c 0.20, CH₂Cl₂; 60% ee). ¹H NMR (300 MHz, CDCl₃): δ = 1.38 (s, 9 H), 2.17 (s, 3 H), 3.86 (d, J = 9.3 Hz, 1 H), 3.97 (dd, J ₁ = 4.5 Hz, J ₂ = 4.4 Hz, 1 H), 6.07 (d, J = 4.5 Hz, 1 H), 6.46 (s, 1 H), 6.63 (d, J = 7.5 Hz, 1 H), 7.05 (t, J = 7.5 Hz, 2 H), 7.19-7.31 (m, 4 H), 7.38-7.48 (m, 4 H), 7.82 (d, J = 7.2 Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 170.5, 142.6, 141.9, 138.3, 137.5, 129.0, 128.6, 128.5, 128.3, 127.9, 127.8, 127.6, 126.9, 125.4, 101.7, 82.2, 66.3, 59.1, 28.8 ppm. IR (KBr):
ν = 3346, 2954, 2926, 2868, 17019, 1544, 1447, 1380, 1158, 840, 775, 738, 704cm^-1. HRMS (Bio TOF Q): m/z calcd for C₂₈H₃₀N₂O₄Na⁺: 481.2098; found: 481.2098. The ee is 60% determined by HPLC [Daicel Chirapak OD-H, hexane-
i-PrOH (98:2), flow rate 1.0 mL/min]: t _R = 6.10 min, 7.86 min.

16

3-( p -Bromophenyl)-2-( tert -butyloxycarbonyl)-4-nitro-5,5-diphenyl-pyrrolidine (3e) Yield 65%; mp 111-112 °C; [α]_D ²⁰ -9.5 (c 0.390, CH₂Cl₂; 49% ee). ¹H NMR (300 MHz, CDCl₃): δ = 1.38 (s, 9 H), 3.84 (d, J = 6.9 Hz, 1 H), 3.95 (dd, J ₁ = 12.0 Hz, J ₂ = 3.0 Hz, 1 H), 5.99 (d, J = 3.6 Hz, 1 H), 6.64 (d, J = 6.3 Hz, 2 H), 7.20 (d, J = 5.4 Hz, 1 H), 7.25 (t, J = 6.1 Hz, 1 H), 7.31 (dd, J ₁ = 1.6, J ₂ = 4.9 Hz, 2 H), 7.37-7.44 (m, 4 H), 7.78 (d, J = 8.1 Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 170.1, 142.4, 141.6, 136.6, 131.8, 129.6, 129.2, 128.5, 127.9, 127.8, 126.8, 125.4, 121.7, 101.5, 82.5, 65.0, 58.3, 27.9 ppm. IR (KBr): ν = 3464, 3312, 2972, 2929, 1728, 1549, 1487, 1449, 1366, 1337, 838, 786, 747, 707 cm^-1. HRMS (Bio TOF Q): m/z calcd for C₂₇H₂₇BrN₂O₄Na⁺: 545.1046; found: 547.1008. The ee is 49% determined by HPLC [Daicel Chirapak OD-H, hexane-i-PrOH (98:2), flow rate 1.0 mL/min]: t _R = 7.53 min, 8.93 min.

17

3-( p -Chlorophenyl)-2-( tert -butyloxycarbonyl)-4-nitro-5,5-diphenyl-pyrrolidine (3f)
Yield 63%; mp 121-122 °C; [α]_D ²⁰ -9.0 (c 0.334, CH₂Cl₂; 46% ee). ¹H NMR (300 MHz, CDCl₃): δ = 1.38 (s, 9 H), 3.83 (d, J = 9.3 Hz, 1 H), 4.00 (dd, J = 4.8 Hz, 1 H), 6.00 (d, J = 4.8 Hz, 1 H), 6.71 (d, J = 8.4 Hz, 2 H), 7.15-7.26 (m, 4 H), 7.29 (t, J = 5.4 Hz, 2 H), 7.37-7.45 (m, 4 H), 7.79 (d, J = 9.0 Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 170.2, 142,4, 141.7, 136.1, 133.6, 129.7, 129.2, 129.1, 128.8, 128.5, 127.9, 127.7, 126.8, 125.4, 101.5, 82.5, 66.1, 58.2, 28.8 ppm. IR (KBr): ν = 3311, 2953, 2971, 2867, 1729, 1592, 1549, 1523, 1490, 1449, 1365, 1339, 837, 786, 745, 706 cm^-1. HRMS (Bio TOF Q): m/z calcd for C₂₇H₂₇ClN₂O₄Na⁺: 501.1552; found: 501.1530. The ee is 46% determined by HPLC [Daicel Chirapak OD-H, hexane-i-PrOH (98:2), flow rate 1.0 mL/min]: t _R = 7.04 min, 8.82 min.

18

3-( p -Fluorophenyl)-2-( tert -butyloxycarbonyl)-4-nitro-5,5-diphenyl-pyrrolidine (3g) Yield 49%; mp 106-107 °C; [α]_D ²⁰ -42.4 (c 0.118, CH₂Cl₂; 40% ee). ¹H NMR (300 MHz, CDCl₃): δ = 1.37 (s, 9 H), 3.83 (d, J = 9.3 Hz, 1 H), 4.01 (dd, J = 5.1 Hz, 1 H), 6.01 (d, J = 5.1 Hz, 1 H), 6.75 (q, J = 5.1 Hz, 2 H), 6.85-6.88 (m, 2 H), 7.22-7.31 (m, 5 H), 7.37-7.44 (m, 4 H), 7.79 (d, J = 8.1 Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 170.2, 163.8, 142.5, 141.6, 133.2, 129.6, 129.5, 129.1, 128.5, 127.9, 127.8, 126.9, 125.5, 115.8, 115.5, 101.6, 82.5, 66.1, 58.1, 27.9 ppm. IR (KBr): ν = 3457, 3311, 2970, 2928, 1729, 1550, 1509, 1367, 1340, 1152, 838, 758, 745, 706 cm^-1. HRMS (Bio TOF Q): m/z calcd for C₂₇H₂₇FN₂O₄Na⁺: m/z = 485.1847; found: 485.1822. The ee is 40% determined by HPLC [Daicel Chirapak OD-H, hexane-i-PrOH (99:1), flow rate 1.0 mL/min]: t _R = 8.34 min, 12.60 min.

19

3-Thienyl-2-( tert -butyloxycarbonyl)-4-nitro-5,5-diphenyl-pyrrolidine (3h) Yield 50%; mp 123-124 °CC; [α]_D ²⁰ -5.3 (c 0.432, CH₂Cl₂; 57% ee). ¹H NMR (300 MHz, CDCl₃): δ = 1.44 (s, 9 H), 3.90-3.93 (d, J = 8.4 Hz, 1 H), 4.30 (dd, J ₁ = 3.8 Hz, J ₂ = 3.9Hz, 1 H), 6.12 (d, J = 4.2 Hz, 1 H), 6.45 (d, J = 3.6 Hz, 1 H), 6.82 (d, J = 3.6 Hz, 1 H), 7.11 (q, J = 1.2 Hz, 1 H), 7.25 (d, J = 3.3 Hz, 4 H), 7.35 (d, J = 8.1 Hz, 2 H), 7.46 (d, J = 1.5 Hz, 2 H), 7.77 (d, J = 1.5 Hz, 2 H) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 170.1, 141.9, 141.6, 140.5, 132.4, 130.0, 129.0, 128.5, 128.2, 127.9, 126.9, 126.8, 125.9, 125.4, 125.0, 101.2, 82.6, 67.3, 53.4, 27.9 ppm. IR (KBr): ν = 3438, 3322, 2979, 2932, 1731, 1551, 1366, 1341, 1154, 1129, 838, 779, 747, 707, 698 cm^-1. HRMS (Bio TOF Q): m/z calcd for C₂₄H₂₆N₂O₄SNa⁺: 473.1472; found: 473.1479. The ee is 57% determined by HPLC [Daicel Chirapak OD-H, hexane-i-PrOH (95:5), flow rate 1.0 mL/min]: t _R = 5.18 min, 6.17 min.